Use of formalin-fixed tissues to determine fumonisin B1-induced sphingolipid alterations in swine

Journal of Veterinary Diagnostic Investigation

Volumn 19, Issue 4, 2007, Pages 425-430

  Hsiao, Shih Hsuan ^a,d   Tumbleson, Mike E ^c,d   Constable, Peter D ^b,d   Haschek, Wanda M ^b,d  

^a Veterinary Diagnostic Laboratory

^b Department of Pathobiology ^*

^c Department of Veterinary Clinical Medicine ^*

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Formalin fixed tissues; Fumonisin B1; Sphinganine; Sphingosine; Swine

Indexed keywords

SUIDAE;

DRUG DERIVATIVE; FORMALDEHYDE; FUMONISIN; FUMONISIN B1; SAFINGOL; SPHINGOLIPID; SPHINGOSINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHEMICALLY INDUCED DISORDER; HEART; KIDNEY; LIVER; LUNG; LUNG EDEMA; METABOLISM; METHODOLOGY; SWINE; SWINE DISEASE; TISSUE FIXATION;

ANIMALS; FORMALDEHYDE; FUMONISINS; HEART; KIDNEY; LIVER; LUNG; PULMONARY EDEMA; SPHINGOLIPIDS; SPHINGOSINE; SWINE; SWINE DISEASES; TISSUE FIXATION;

EID: 34547835733     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870701900417     Document Type: Article

References (20)

1. Abnet CC, Borkowf CB, Qiao YL, et al.: 2001, Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in China. Cancer Causes Control 12:821-828.
2. Castegnaro M, Garren L, Galendo D, et al.: 1998, Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposure. J Chromatogr B Biomed Sci Appl 720:15-24.
3. Fox CH, Johnson FB, Whiting J, Roller PP: 1985, Formaldehyde fixation. J Histochem Cytochem 33:845-853.
4. 1 in rabbits: nephrotoxicity and sphingolipid alterations. Nat Toxins 3:395-403.
5. 1, a toxic metabolite of Fusarium moniliforme. J Vet Diagn Invest 2:217-221.
6. Haschek WM, Gumprecht LA, Smith G, et al.: 2001, Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives. Environ Hlth Perspect 109(suppl 2):251-257.
7. Merrill AH Jr, Wang E, Mullins RE, et al.: 1988, Quantitation of free sphingosine in liver by high-performance liquid chromatography. Anal Biochem 171:373-381.
8. Riley RT, An NH, Showker JL, et al.: 1993, Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicol Appl Pharmacol 118:105-112.
9. Riley RT, Enongene E, Voss KA, et al.: 2001, Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ Health Perspect 109(suppl 2):301-308.
10. Riley RT, Norred WP, Wang E, Merrill AH Jr: 1999, Alteration in sphingolipid metabolism: bioassays for fumonisin-and ISP-I-like activity in tissues, cells and other matrices. Nat Toxins 7:407-414.
11. Riley RT, Wang E, Merrill AH Jr: 1994, Liquid chromatography of sphinganine and sphingosine: use of sphinganine to sphingosine ratio as a biomarker for consumption of fumonisins. J AOAC Int 77:533-540.
12. 1 during an eight-week period: growth and clinical parameters. Nat Toxins 4:42-50.
13. 1 decreases cardiovascular function but does not alter pulmonary capillary permeability in swine. Toxicol Sci 56:240-249.
14. Smith GW, Constable PD, Tumbleson ME, et al: 1999, Sequence of cardiovascular changes leading to pulmonary edema in swine fed culture material containing fumonisin. Am J Vet Res 60:1292-1300.
15. Solfrizzo M, Avantaggiato G, Visconti A: 1997, Rapid method to determine sphinganine/sphingosine in human and animal urine as a biomarker for fumonisin exposure. J Chromatogr B Biomed Sci Appl 692:87-93.
16. Suzuki K: 1965, The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, postmortem changes and the effect of formalin preservation. J Neurochem 12:629-638.
17. 1 exposure in ducks. Chem Biol Interact 146:61-72.
18. Wang E, Norred WP, Bacon CW, et al.: 1991, Inhibition of sphingolipid biosynthesis by fumonisins: implications for diseases associated with Fusarium moniliforme. J Biol Chem 266:14486-14490.
19. 1 levels associated with an epizootic of equine leukoencephalomalacia. J Vet Diagn Invest 2:213-216.
20. 1. Toxicol In Vitro 10:77-84.